Company Profile
Updated: 28-OCT-09Otsuka Pharmaceutical Company Ltd.
International Private company
2-16-4 Konan, Minato-ku, Tokyo, 108-8242, Japan
()81 03 6717 1400, 81 03 6717 1499 fax, http://www.otsuka.com
Primary SIC: Pharmaceutical Preparations, Primary NAICS: Pharmaceutical Preparation Manufacturing
Description: Manufacturing: Manufacture and distribution of pharmaceuticals, food products, medical equipment and clinical testing equipment
View this company profile - Now for a Limited Time, try Goliath Company Profiles
Free for 3 Days!
National Pharmaceutical Council Welcomes New Member, Otsuka America Pharmaceutical, Inc.
PR Newswire; 12/23/2009; 637 words; ...specialty healthcare company that commercializes...is part of the Otsuka Pharmaceutical...established in 1989 by Otsuka America, Inc...wholly owned by Otsuka Pharmaceutical Co., Ltd. (OPC). In...research-based pharmaceutical companies, including Abbott...Bayer ...
NATIONAL PHARMACEUTICAL COUNCIL WELCOMES NEW MEMBER, OTSUKA AMERICA PHARMACEUTICAL, IN.(Company overview)
States News Service; 12/21/2009; 705 words; ...specialty healthcare company that commercializes...is part of the Otsuka Pharmaceutical...established in 1989 by Otsuka America, Inc...wholly owned by Otsuka Pharmaceutical Co., Ltd. (OPC). In...research-based pharmaceutical companies, including Abbott...Bayer ...
Galenea and Otsuka Announce Second Extension to Schizophrenia Research Collaboration.
Biotech Week; 12/16/2009; 1095 words; ...million. The companies have been working...support from Otsuka, we expect...Director of Otsuka Pharmaceutical Co., Ltd. "Through...commitment of Otsuka to Galenea...Neurosurgery, Otsuka Pharmaceuticals Company Ltd., Pharmaceutical...
U.S. Food and Drug Administration Approves ABILIFY[R] aripiprazole for the Treatment of Irritability Associated with Autistic Disorder in Pediatric Patients Ages 6 to 17 Years.
Psychology & Psychiatry Journal; 12/12/2009; 2042 words; Bristol-Myers Squibb Company (NYSE: BMY) and Otsuka Pharmaceutical Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental New Drug Application (sNDA) for...
Research and Markets Offers Report: CNS Therapeutics - A World Market Review
Wireless News; 12/7/2009; 490 words; ...market analyses Companies Profiled - Abbott...Pharma Co., Ltd. (Japan...Fabre-Kramer Pharmaceuticals, Inc. (USA...Hoffmann-La Roche Ltd. (Switzerland...Inc. (USA) - Otsuka Pharmaceutical Co., Ltd. (Japan...
Recent News Articles
- Otsuka Pharmaceutical Co., Ltd.-Company Report.
M2 Presswire - February 05, 2009 - Acucela and Otsuka to co-develop rebamipide.(Otsuka Pharmaceutical Company Ltd.)(Brief article)
Pharma Marketletter - September 15, 2008 - Abilify (aripiprazole) can now be used as an adjunctive therapy to either lithium or valproate for the acute treatment of manic and mixed episodes associated with bipolar I disorder with or without psychotic features in adults.(NEW INDICATIONS)(Otsuka Pharmaceutical Company Ltd. and Bristol-Myers Squibb Co.)(Brief article)
Drug Topics - June 16, 2008 - Adendum: Otsuka USA.(Otsuka Pharmaceutical Company Ltd.)(Brief article)
Pharma Marketletter - February 05, 2007
Why Purchase This Company Profile?
- Sales prospecting
- Competitive analysis
- Vendor & supplier evaluation
- Customer evaluation and analysis
- Strategic planning